Recall · openFDA Food Enforcement
Lipodrene With 25mg Ephedra Extract 100CT UPC 8 57084 00056 9: FDA Recall F-0647-2021 Agency action: May 12, 2021 Record ID: F-0647-2021
View official source ↗ What happened Original notice title
Lipodrene With 25mg Ephedra Extract 100CT UPC 8 57084 00056 9, recall F-0647-2021
From the archived source record
The firm was notified by the FDA that the product contains the unapproved food additive 1,4-dimethylamylamine (DMAA).
What the official notice says to do Check the original notice for the instructions that apply to the named product, company, and affected lots.
Read the official notice → Status and source details
Status recorded in the archive Ongoing
FDA recall classification Class II
Recall initiated by Voluntary: Firm initiated
Report date Jun 9, 2021
Source checked Jul 16, 2026
Record revision 2c06b6fa4300 This is a dated record. Its current status may have changed since the source was captured. A record applies to its stated scope; it is not a safety rating for every product from a company.
Sources, dates, and coverage → What is affected Product Lipodrene With 25mg Ephedra Extract 100CT UPC 8 57084 00056 9 Company Hi Tech Pharmaceuticals Lot / identifier Lot # 001211197, Exp. 12/25 Market / distribution The product was shipped to the following states: AL, AZ, CA, CO, CT, FL, GA, IA, ID, IL, IN, KS, LA, MA, MD, ME, MI, MO, MS, MT, NC, NE, NE, NJ, NM, NV, NY, OH, OK, OR, PA, PR, TN, TX, UT, VA, VT, WA & WI. Quantity reported 19,068/100 ct bottles What is affected Product Lipodrene With 25mg Ephedra Extract 100CT UPC 8 57084 00056 9 Company Hi Tech Pharmaceuticals Lot / identifier Lot # 001211197, Exp. 12/25 Market / distribution The product was shipped to the following states: AL, AZ, CA, CO, CT, FL, GA, IA, ID, IL, IN, KS, LA, MA, MD, ME, MI, MO, MS, MT, NC, NE, NE, NJ, NM, NV, NY, OH, OK, OR, PA, PR, TN, TX, UT, VA, VT, WA & WI. 